What are the complications of percutaneous interventional treatment for liver cancer? The following are the common ones

Percutaneous intervention is a common method for liver cancer treatment. It may cause complications and symptoms for patients, the most common of which are bleeding, liver and kidney damage, etc. If necessary, medication is needed to resolve the symptoms.

Cancer is treated actively, even liver cancer. Patients can choose many treatment methods, and the most commonly used one is percutaneous intervention. So, what are the complications of percutaneous intervention for liver cancer?
Interventional treatment of liver cancer <br/>Interventional treatment of liver cancer is a common vascular treatment, that is, when patients undergo hepatic artery chemoembolization, they will experience some complications, the most common of which are low-grade fever, chest tightness, etc. Some patients will have a poor appetite, which are all post-embolism syndrome. After puncture through the percutaneous route, patients will experience pneumothorax, bleeding, bile duct injury, etc., and the patients will have breathing problems, and may even have pain or infection.
Specific sequelae <br/>Interventional surgery for liver cancer is a minimally invasive surgical treatment and a relatively safe treatment method. Most patients can tolerate it. Patients may have some complications, the most common of which is bleeding, including bleeding at the common puncture site and ruptured bleeding of tumor blood vessels inside the liver. During the interventional treatment, chemotherapy drugs may be used. Both drugs and contrast agents can damage the kidney and liver functions of the human body. Common pain in the liver area, abdominal distension, and fever are related to the patient's tumor necrosis, and there may even be gastrointestinal reactions. Patients may experience nausea and vomiting, which are adverse reactions to chemotherapy and can be treated with antiemetic drugs.